Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.35), $0.08 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.